Detalhe da pesquisa
1.
Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development.
Immunity
; 56(1): 58-77.e11, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521495
2.
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma.
Nat Immunol
; 16(12): 1235-44, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26502405
3.
Immunotherapy and transplantation for hepatocellular carcinoma.
J Hepatol
; 80(5): 822-825, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253289
4.
Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
Gastroenterology
; 165(4): 1053-1063.e6, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429366
5.
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.
Gastroenterology
; 164(1): 72-88.e18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108710
6.
Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis.
Ann Surg Oncol
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334851
7.
Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy.
Eur Radiol
; 34(1): 475-484, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540318
8.
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.
PLoS Genet
; 17(6): e1009589, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166362
9.
Improved outcomes of liver resection for hepatitis C-related hepatocellular carcinoma after the introduction of direct-acting antiviral therapy.
HPB (Oxford)
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735814
10.
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.
Gut
; 72(4): 736-748, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35584893
11.
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification.
Gut
; 72(1): 129-140, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197323
12.
Semiautomated segmentation of hepatocellular carcinoma tumors with MRI using convolutional neural networks.
Eur Radiol
; 33(9): 6020-6032, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071167
13.
Tumor burden in patients with early and intermediate-stage hepatocellular carcinoma undergoing liver resection: a retrospective multicenter study on clinical and oncological outcomes.
HPB (Oxford)
; 25(7): 836-844, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098458
14.
Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
Gastroenterology
; 161(3): 879-898, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34126063
15.
Surgical Treatments of Hepatobiliary Cancers.
Hepatology
; 73 Suppl 1: 128-136, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438491
16.
DNA Methylation Profiling of Human Hepatocarcinogenesis.
Hepatology
; 74(1): 183-199, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33237575
17.
Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology.
Eur Radiol
; 32(9): 6493-6503, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380226
18.
Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
HPB (Oxford)
; 24(4): 470-477, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34544629
19.
Outcomes of transplantation for HBV- vs. HCV-related HCC: impact of DAA HCV therapy in a national analysis of >20,000 patients.
HPB (Oxford)
; 24(7): 1082-1090, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34955348
20.
Left lateral segment pediatric liver transplantation: a 25 year experience at Mount Sinai.
HPB (Oxford)
; 24(6): 817-824, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742650